|
Volumn 69, Issue 8, 2001, Pages 915-922
|
Carbetapentane attenuates kainate-induced seizures via σ-1 receptor modulation
|
Author keywords
1 receptor; Anticonvulsant; Carbetapentane; Fos related antigen immunoreactivity; Hippocampus; Kainic acid; Neuroprotection; Seizures
|
Indexed keywords
KAINIC ACID;
N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE;
PENTOXYVERINE;
RECEPTOR BLOCKING AGENT;
SIGMA 1 OPIATE RECEPTOR;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
CELL LOSS;
CONTROLLED STUDY;
CONVULSION;
DOSE RESPONSE;
DRUG EFFECT;
HIPPOCAMPUS;
IMMUNOREACTIVITY;
MALE;
MORTALITY;
NEUROTOXICITY;
NONHUMAN;
RAT;
SEIZURE;
ANIMALS;
BRAIN;
CELLS, CULTURED;
CYCLOPENTANES;
DRUG INTERACTIONS;
IMMUNOHISTOCHEMISTRY;
KAINIC ACID;
MALE;
OXAZINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, SIGMA;
SEIZURES;
|
EID: 0035854389
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(01)01181-X Document Type: Article |
Times cited : (16)
|
References (20)
|